Funded Tech Companies

Immune Control

Immune Control, operating out of West Conshohocken, received equity investments through Domain Associates, NewSpring Capital and private investors.

Company Overview

Company Name
Immune Control
Company Status
Acquired or Merged
Funding Rounds

Contact Information

Mailing Address
200 Barr Harbor Drive 450
West Conshohocken, PA 19428
USA

Company Background Information

Overview
Immune Control, Inc. is a pharmaceutical company developing compounds for treatment of multiple myeloma and other immunological diseases.
Profile
Immune Control LinkedIn Company Profile
Social Media
Immune Control Company Twitter Account
Company News
Immune Control News
Facebook
Immune Control on Facebook
YouTube
Immune Control on YouTube
Last Transaction
6/30/2008

Financing History

Date
Type
Amount
Venture Equity
$6,004,000
Venture Equity
$2,800,000
Venture Equity
$11,300,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Mark Strobeck
  Mark Strobeck LinkedIn Profile  Mark Strobeck Twitter Account  Mark Strobeck News  Mark Strobeck on Facebook
VP - Finance
Anne Shiflett
  Anne Shiflett LinkedIn Profile  Anne Shiflett Twitter Account  Anne Shiflett News  Anne Shiflett on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Immunai | Immune Design

 

Share this article

 


About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary